Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottstein, U.
Right arrow Articles by Paulson, O. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottstein, U.
Right arrow Articles by Paulson, O. B.

(Stroke. 1972;3:560.)
© 1972 American Heart Association, Inc.


The Effect of Intracarotid Aminophylline Infusion on the Cerebral Circulation

U. Gottstein M.D.1 O. B. Paulson M.D.2

1 Department of Medicine Bürgerhospital, 6 Frankfurtam Main, Germany
2 Department of Psychiatry, Bispebjerg Hospital, 2400 Copenhagen NV, Denmark

The influence of aminophylline infusion into the internal carotid artery on cerebral blood flow (CBF) was studied in 12 patients. Six of them were studied using the N2O saturation technique of Kety and Schmidt, and the other six using the Xenon-133 intra-arterial injection method of Lassen and Ingvar. Intracarotid infusion of aminophylline resulted in a significant decrease of CBF. Previous studies have shown that aminophylline also reduced CBF when injected intravenously. Furthermore, in the present study it was demonstrated that a small dose of aminophylline which was without cerebral vasoconstricting effect when infused intravenously still reduced CBF when infused into the internal carotid artery. Thus aminophylline is a cerebral vasoconstrictor due to a local action on the cerebral vessels.


Key Words: cerebral blood flow • Kety-Schmidt method • vasoconstrictor • Xenon-133 intra-arterial injection method




This article has been cited by other articles:


Home page
Vasc MedHome page
M. Davis and D. Barer
Neuroprotection in acute ischaemic stroke. II: Clinical potential
Vascular Medicine, August 1, 1999; 4(3): 149 - 163.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
R. R. Clancy, K. M. Kaplan, S. Baumgart, and K. R. Rosenberry
Neonatal Theophylline Neurotoxicity
Clinical Pediatrics, March 1, 1985; 24(3): 168 - 170.
[Abstract] [PDF]


Home page
JAMAHome page
J. E. Clark and J. K. Devenport
Theophylline Exacerbating Spasticity
JAMA, July 22, 1983; 250(4): 485 - 485.
[Abstract] [PDF]


Home page
ScienceHome page
J. Thurston, R. Hauhard, and J. Dirgo
Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice
Science, August 18, 1978; 201(4356): 649 - 651.
[Abstract] [PDF]